BRAIN Biotech AG (ETR:BNN) reported disappointing yearly results, missing revenue predictions by 4.0% and a larger loss per share than expected. Analysts forecast a 9.4% revenue increase in 2025 and a 44% reduction in loss per share.
Read MoreDid you find this insightful?
Bad
Just Okay
Amazing